Association Between Copayment Amount and Filling of Medications for Angiotensin Receptor Neprilysin Inhibitors in Patients With Heart Failure

Background Angiotensin receptor neprilysin inhibitors (ARNI) reduce mortality and hospitalization for patients with heart failure. However, relatively high copayments for ARNI may contribute to suboptimal adherence, thus potentially limiting their benefits. Methods and Results We conducted a retrosp...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American Heart Association Ročník 11; číslo 24; s. e027662
Hlavní autoři:	Mukhopadhyay, Amrita, Adhikari, Samrachana, Li, Xiyue, Dodson, John A., Kronish, Ian M., Shah, Binita, Ramatowski, Maggie, Chunara, Rumi, Kozloff, Sam, Blecker, Saul
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England John Wiley and Sons Inc 20.12.2022 Wiley
Témata:	Angiotensin Receptor Antagonists - therapeutic use angiotensin receptor‐neprilysin inhibitor Biphenyl Compounds - therapeutic use copayment Drug Combinations Heart Failure Humans medication adherence Neprilysin - antagonists & inhibitors Original Research out‐of‐pocket cost Retrospective Studies sacubitril‐valsartan Stroke Volume Tetrazoles - therapeutic use Treatment Outcome Valsartan - therapeutic use Ventricular Function, Left heart failure medication adherence out‐of‐pocket cost sacubitril‐valsartan angiotensin receptor‐neprilysin inhibitor copayment
ISSN:	2047-9980, 2047-9980
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!